Global 3D Bioprinting Market

$2,600.00

产品代码: GB03362R 行业: 地区:

在 2021, the global 3d bioprinting market stood at USD 817 百万. 复合年增长率为 17.3% 从 2022 到 2028, 预计价值将达到 ~USD 2,496 百万 2028, 根据 Gen Consulting 公司的一份新报告.

该报告提供了有关当前全球市场情况的深入分析和见解, latest trends and drivers into global 3d bioprinting market. 它提供了对市场规模等各种细节的独家见解, 主要趋势, 竞争格局, 增长率和细分市场. This study also provides an analysis of the impact of the COVID-19 crisis on the 3d bioprinting industry.

该行业报告提供了全球市场的市场估计和预测, 接下来是对组件的详细分析, 技术, 材料, 应用, 最终用户, 和地区. The global market for 3d bioprinting can be segmented by components: 3D bioprinters, bioinks. 3d bioprinting market is further segmented by technology: inkjet bioprinting, laser assisted bioprinting, magnetic levitation bioprinting, syringe/extrusion bioprinting, 其他的. 根据材料, the 3d bioprinting market is segmented into: extracellular matrices, hydrogels, living cells, 其他的. 根据应用, the 3d bioprinting market also can be divided into: 临床, 研究. 3d bioprinting market by end user is categorized into: 生物制药公司, regenerative medicine companies, research organizations & academic institutes, 其他的. The 3d bioprinting market by region can be segmented into: 亚太地区, 欧洲, 北美, 世界其他地区 (排).

按成分分类:
– 3D bioprinters
bioinks

按技术:
inkjet bioprinting
laser assisted bioprinting
magnetic levitation bioprinting
syringe/extrusion bioprinting
– 其他的

按材质:
extracellular matrices
hydrogels
living cells
– 其他的

按申请:
– 临床
– 研究

按最终用户:
– 生物制药公司
regenerative medicine companies
research organizations & academic institutes
– 其他的

按地区:
– 亚太地区
– 欧洲
– 北美
– 世界其他地区 (排)

The report also provides a detailed analysis of several leading 3d bioprinting market vendors that include 3D Systems Corporation (Allevi, 公司), Advanced Solutions Life Sciences, 有限责任公司 (ASLS), Aspect Biosystems Ltd., BICO Group AB (Formerly Cellink AB), Cyfuse Biomedical K.K., EnvisionTEC GmbH (桌面金属公司), GeSIM GmbH, Inventia Life Science Pty Ltd., Nano3D Biosciences, 公司. (n3D), 欧加诺沃控股公司, Poietis SAS, regenHU Ltd., Regenovo Biotechnology Co., 有限公司, ROKIT Healthcare, INC., Stratasys Ltd., Vivax Bio, 有限责任公司 (3D Bioprinting Solutions), 除其他外.
*索取免费样品以获得完整的公司列表

历史 & 预测期
本研究报告对各个细分市场进行了分析 2018 到 2028 考虑到 2021 为基准年.

报告范围
To analyze and forecast the market size of the global 3d bioprinting market.
To classify and forecast the global 3d bioprinting market based on components, 技术, 材料, 应用, 最终用户, 地区.
To identify drivers and challenges for the global 3d bioprinting market.
– 检查合并等竞争性发展 & 收购, 协议, 合作与伙伴关系, ETC。, in the global 3d bioprinting market.
To identify and analyze the profile of leading players operating in the global 3d bioprinting market.

为什么选择这份报告
Gain a reliable outlook of the global 3d bioprinting market forecasts from 2022 到 2028 跨场景.
– 确定投资的增长领域.
– 通过公司简介和市场数据领先于竞争对手.
– Excel 格式的跨场景分析易用性的市场预估.
– 三个月的战略咨询和研究支持.
– 为单用户许可证提供打印验证.

Global 3D Bioprinting Market

对这份报告感兴趣? 立即获取免费样品!
Global 3D Bioprinting Market - 报告范围
报告属性

细节

基准年

2021

预测年份

2022-2028

复合年增长率 (2022-2028)

17.3%

页数

91

行业参与者

3D系统公司 (Allevi Inc.), Advanced Solutions Life Sciences LLC (ASLS), Aspect Biosystems Ltd., BICO Group AB (Formerly Cellink AB), Cyfuse Biomedical K.K., EnvisionTEC GmbH (桌面金属公司), GeSIM GmbH, Inventia Life Science Pty Ltd., Nano3D Biosciences Inc. (n3D), 欧加诺沃控股公司, Poietis SAS, regenHU Ltd., Regenovo Biotechnology Co. 有限公司, ROKIT Healthcare INC., Stratasys Ltd., Vivax Bio LLC (3D Bioprinting Solutions)

相关报道
想要定制此报告?
本报告可以灵活地根据您的具体需求进行定制. 我们的分析师和行业专家团队将直接与您合作,全面了解您的需求.
滚动至顶部

下载免费样品 - Global 3D Bioprinting Market

请填写我们的表格,我们会尽快回复您.